Partnership Opportunities

Showcase Your Brand to the Leading Minds of HFpEF & HCM Drug Discovery & Development

Partnering with the 2nd HFpEF & HCM Drug Discovery & Development Summit is a proven way to attract the attention of key cardiovascular decision makers and influence their decisions as big pharma race to become the biggest name in HFpEF and HCM.

This is your opportunity to influence future partnering decisions and ensure biotech and pharma know of your capabilities in advance, to place you above your competitors and get ahead of the curve.

We’ll work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your 2023 commercial objectives.

Don’t miss this unique opportunity to demonstrate your preclinical models, biomarkers, diagnostic validation, clinical endpoint targets and more to meet the increasing demands of this fast-growing field!

Who Attends?

Who will you meet

Current Partners:

AnaBios logo
Antaros Medical AB

Experts Need Your Help With:

  • Evaluating drugs targeting metabolic disorders, fibrosis or cardiovascular complications
  • Developing gene therapy approaches for inherited heart diseases
  • Assessing clinical trial outcomes by measuring cardiac output
    And more!


Why Partner?

EMPLOY your valuable time and resources by learning how the leading companies in the space are advancing successful clinical trials for HFpEF and HCM drug development


INCORPORATE your understanding of the mechanisms driving HFpEF in identifying novel targets to shape new research in HFpEF and rare cardiomyopathies

DEVELOP new and strengthen existing connections with key thought leaders to advise and steer your pipeline’s acceleration